Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person11
HUMANA INC
Company
Humacyte, Inc.
Company
DANA Inc
Company
HUYA Inc.
Company
Asana, Inc.
Company
HP INC
Company
HUBBELL INC
Company
HUBSPOT INC
Company
Hub Group, Inc.
Company
DNA X, Inc.
Company
Astrana Health, Inc.
Company
Primary record7
HUMANA INC filed 8-K
Item 2.02 Results of Operations and Financial Condition. Item 7.01 Regulation FD Disclosure. Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended September 30,
Vaxart, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 16, 2026, following a recommendation by the Nominati
HUMANA INC filed 8-K
Item 7.01 Regulation FD Disclosure. Blackrock Joint Venture Humana Inc. (the Company ) issued a press release today reporting its entry into a new joint venture arrangement with funds and accounts managed by HPS Investme
HUMANA INC filed 8-K
Item 7.01 Regulation FD Disclosure. Supplementary Audio Commentary Supplementary audio commentary from Humana s President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana s Investor Relations page at
HUMANA INC filed 8-K
Item 7.01 Regulation FD Disclosure. Supplementary Audio Commentary Supplementary audio commentary from Humana s President and Chief Executive Officer, Jim Rechtin, may be accessed via Humana s Investor Relations page at
HUMANA INC filed 4
SEC form 4 filed by HUMANA INC (CIK 49071) on 2026-09-03.
HUMANA INC filed 8-K
Item 7.01. Regulation FD Disclosure. Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between September 1, 2026 and September 30, 2026.